Many important SLC22 genes—including those of the OAT and OAT-related groups—had decreased expression over the continuum of stages of renal cell carcinoma from well-functioning, healthy kidneys to advanced metastatic disease. This evidence concerns the gene OAT and metastatic neoplasm.